Evidence map›Paper›PMID 38758998›Full record

ArticleJournal of Alzheimer's disease : JAD2024

Effects of Type 2 Diabetes on the Neuropsychological Profile in Mild Cognitive Impairment.

José A Reyes Bueno, Guillermo Sánchez-Guijo, Pablo Doblas Ráez, Juan A García-Arnés, Francisco J Garzón-Maldonado, Vicente Serrano Castro, Carlos de la Cruz-Cosme, Carmen Alba-Linero, Mario Gutiérrez-Bedmar, Natalia García-Casares

Abstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

José A Reyes BuenoDepartamento de Neurología, Hospital Universitario Regional de Málaga, Málaga, Spain.
Guillermo Sánchez-GuijoDepartamento de Medicina, Facultad de Medicina, Universidad de Málaga, Málaga, Spain.
Pablo Doblas RáezDepartamento de Medicina, Facultad de Medicina, Universidad de Málaga, Málaga, Spain.
Juan A García-ArnésDepartamento de Medicina, Facultad de Medicina, Universidad de Málaga, Málaga, Spain.
Francisco J Garzón-MaldonadoDepartamento de Neurología, Hospital Universitario Virgen de la Victoria de Málaga, Málaga, Spain.
Vicente Serrano CastroDepartamento de Neurología, Hospital Universitario Virgen de la Victoria de Málaga, Málaga, Spain.
Carlos de la Cruz-CosmeDepartamento de Medicina, Facultad de Medicina, Universidad de Málaga, Málaga, Spain.
Carmen Alba-LineroDepartamento de Medicina, Facultad de Medicina, Universidad de Málaga, Málaga, Spain.
Mario Gutiérrez-BedmarDepartamento de Medicina, Facultad de Medicina, Universidad de Málaga, Málaga, Spain.
Natalia García-CasaresDepartamento de Medicina, Facultad de Medicina, Universidad de Málaga, Málaga, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Diabetes is one of the main risk factors for developing mild cognitive impairment (MCI) and Alzheimer's disease. Most studies have demonstrated a worse performance in executive function, verbal fluency, and information processing speed in patients with diabetes. Objective: To assess the cognitive functioning of persons with type 2 diabetes and amnesic mild cognitive impairment (aMCI-T2DM) compared to persons with aMCI without diabetes and persons without diabetes or aMCI as controls, to understand the role of diabetes in the neuropsychological profile. Methods: Cross-sectional study involving a sample of 83 patients, ranging in age from 61 to 85 years and divided into three groups: aMCI-T2DM (27 patients), aMCI (29 patients), Controls (27 individuals). All the participants undertook an exhaustive neuropsychological assessment (auditory-verbal and visual memory, attention, information processing speed, language, executive function, and depression). Results: Both groups of aMCI patients performed significantly worse than the controls in all the neuropsychological tests. A significant linear tendency (p trend < 0.05) was found between groups, with the aMCI-T2DM group presenting worse results in global cognition assessed by the Mini-Mental State Examination and Montreal Cognitive Assessment; Rey-Osterrieth Complex Figure Test; Auditory Verbal Learning Test; Trail Making Test A and B, Verbal Fluency Test, and Hamilton Depression Rating Scale. Conclusions: aMCI patients with or without diabetes showed worse cognitive function compared to persons without diabetes or aMCI. Additionally, aMCI patients without T2DM presented a different cognitive profile than aMCI patients with T2DM, which tended towards presenting worse cognitive functions such as global cognition, memory, attention, executive function, and language.

Indexed as

Cognitive DysfunctionDiabetes Mellitus, Type 2Executive FunctionNeuropsychological TestsAgedAged, 80 and overAttentionCross-Sectional StudiesFemaleHumansMaleMiddle AgedAlzheimer’s diseasecognitiondiabetes mellitusmild cognitive impairmentneuropsychological testtype 2 diabetes

Identifiers

PMID38758998
PMCPMC11191518

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.